Retrograde transport of intact poliovirus through the axon via the fast transport system

Virology

Volumn 250, Issue 1, 1998, Pages 67-75

  Ohka, Seii ^a   Yang, Wei Xing ^a   Terada, Eiji ^b   Iwasaki, Kuniko ^a   Nomoto, Akio ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL TISSUE; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; RETROGRADE NERVE FIBER TRANSPORT; SCIATIC NERVE; VIRUS GENE; VIRUS PATHOGENESIS; VIRUS TRANSMISSION;

ANIMALIA; MUS MUSCULUS; POLIOVIRUS; RNA VIRUSES;

EID: 0032505637     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9360     Document Type: Article

References (29)

1. Abe S., Ota Y., Doi Y., Nomoto A., Nomura T., Chumakov K. M., Hashizume S. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus. Virology. 210:1995a;160-166.
2. Abe S., Ota Y., Koike S., Kurata T., Horie H., Nomura T., Hashizume S., Nomoto A. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice. Virology. 206:1995b;1075-1083.
3. Arita M., Koike S., Aoki J., Horie H., Nomoto A. Interaction of poliovirus with its purified receptor and conformational alteration in the virion. J. Virol. 1998.
4. Bodian D. Viremia in experimental poliomyelitis. II. Viremia and the mechanism of the "provoking effect" of injections or trauma. Am. J. Hyg. 60:1954;358-370.
5. Bodian D. Emerging concept of poliomyelitis infection. Science. 122:1955;105-108.
6. Bouchard M. J., Lam D. H., Racaniello V. R. Determinants of attenuation and temperature sensitivity in the type 1 poliovirus Sabin vaccine. J. Virol. 69:1995;4972-4978.
7. Brady S. T. Molecular motors in the nervous system. Neuron. 7:1991;521-533.
8. Brown R. H. Jr., Johnson D., Ogonowski M., Weiner H. L. Type 1 human poliovirus binds to human synaptosomes. Ann. Neurol. 21:1987;64-70.
9. Gromeier M., Wimmer E. Mechanism of injury-provoked poliomyelitis. J. Virol. 72:1998;5056-5060.
10. Hirokawa N., Sato-Yoshitake R., Kobayashi N., Pfister K. K., Bloom G. S., Brady S. T. Kinesin associates with anterogradely transported membranous organelles in vivo. J. Cell Biol. 114:1991;295-302.
11. Hirokawa N., Sato-Yoshitake R., Yoshida T., Kawashima T. Brain dynein (MAP1C) localizes on both anterogradely and retrogradely transported membranous organelles in vivo. J. Cell Biol. 111:1990;1027-1037.
12. Horie H., Koike S., Kurata T., Sato-Yoshida Y., Ise I., Ota Y., Abe S., Hioki K., Kato H., Taya C., Nomura T., Hashizume S., Yonekawa H., Nomoto A. Transgenic mice carrying the human poliovirus receptor: New animal model for study of poliovirus neurovirulence. J. Virol. 68:1994;681-688.
13. Howe H., Bodian D. Neuronal Mechanisms in Poliomyelitis. 1942;Commonwealth FundHumphrey MilfordOxford University Press, New York, London.
14. Kohara M., Abe S., Komatsu T., Tago K., Arita M., Nomoto A. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain. J. Virol. 62:1988;2828-2835.
15. Koike S., Aoki J., Nomoto A. Transgenic mouse for the study of poliovirus pathogenicity. Cellular Receptors for Animal Viruses. 1994a;Cold Spring Harbor Laboratory Press, Cold Spring Harbor. p. 463-480.
16. Koike S., Horie H., Ise I., Okitsu A., Yoshida M., Iizuka N., Takeuchi K., Takegami T., Nomoto A. The poliovirus receptor protein is produced both as membrane-bound and secreted forms. EMBO J. 9:1990;3217-3224.
17. Koike S., Taya C., Aoki J., Matsuda Y., Ise I., Takeda H., Matsuzaki T., Amanuma H., Yonekawa H., Nomoto A. Characterization of three different transgenic mouse lines that carry human poliovirus receptor gene: Influence of the transgene expression on pathogenesis. Arch. Virol. 139:1994b;351-363.
18. Koike S., Taya C., Kurata T., Abe S., Ise I., Yonekawa H., Nomoto A. Transgenic mice susceptible to poliovirus. Proc. Natl. Acad. Sci. USA. 88:1991;951-955.
19. Li T., Zhang A., Iizuka N., Nomoto A., Arnold E. Crystallization and preliminary X-ray diffraction studies of coxsackievirus B1. J. Mol. Biol. 223:1992;1171-1175.
20. Lonberg-Holm K., Gosser L. B., Kauer J. C. Early alteration of poliovirus in infected cells and its specific inhibition. J. Gen. Virol. 27:1975;329-342.
21. Madshus I. H., Olsnes S., Sandvig K. Mechanism of entry into the cytosol of poliovirus type 1: Requirement for low pH. J. Cell Biol. 98:1984;1194-1200.
22. Nathanson N., Bodian D. Experimental poliomyelitis following intramuscular virus injection. I. The effect of neural block on a neurotropic and a pantropic strain. Bull Johns Hopkins Hosp. 108:1961;308-319.
23. Nathanson N., Langmuir A. D. The Cutter incident: poliomyelitis following formaldehyde-inactivated poliovirus vaccination in the United States during the spring of 1955. III. Comparison of the clinical character of vaccinated and contact cases occurring after use of high rate lots of Cutter vaccine. Am. J. Hyg. 78:1963;61-81.
24. Ren R., Costantini F., Gorgacz E. J., Lee J. J., Racaniello V. R. Transgenic mice expressing a human poliovirus receptor: A new model for poliomyelitis. Cell. 63:1990;353-362.
25. Ren R., Racaniello V. R. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 166:1992;747-752.
26. Sabin A. B., Boulger L. R. History of Sabin attenuated poliovirus oral live vaccine strains. J. Biol. Stand. 1:1973;115-118.
27. Shiroki K., Ishii T., Aoki T., Kobashi M., Ohka S., Nomoto A. A new cis-acting element for RNA replication within the 5′ noncoding region of poliovirus type 1 RNA. J. Virol. 69:1995;6825-6832.
28. Tyler K. L., McPhee D. A., Fields B. N. Distinct pathways of viral spread in the host determined by reovirus S1 gene segment. Science. 233:1986;770-774.
29. Yang W.-X., Terasaki T., Shiroki K., Ohka S., Aoki J., Tanabe S., Nomura T., Terada E., Sugiyama Y., Nomoto A. Efficient delivery of circulating poliovirus to the central nervous system independently of poliovirus receptor. Virology. 229:1997;421-428.